[1]闫贵国,郭淑红,石晓娟,等.养血清脑颗粒联合阿替普酶治疗急性脑梗死的疗效及对患者炎症因子和凝血功能的影响[J].内科,2018,13(04):574-577.[doi:DOI:10.16121/j.cnki.cn45-1347/r.2018.04.11]
 YAN Guiguo,GUO Shuhong,SHI Xiaojuan,et al.Efficacy of Yangxue Qing Nao granule combined with alteplase in treating acute cerebral infarction and its effects on inflammatory factors and coagulation function[J].Internal Medicine of China,2018,13(04):574-577.[doi:DOI:10.16121/j.cnki.cn45-1347/r.2018.04.11]
点击复制

养血清脑颗粒联合阿替普酶治疗急性脑梗死的疗效及对患者炎症因子和凝血功能的影响()
分享到:

《内科》[ISSN:1006-6977/CN:61-1281/TN]

卷:
13卷
期数:
2018年04
页码:
574-577
栏目:
论著
出版日期:
2018-08-13

文章信息/Info

Title:
Efficacy of Yangxue Qing Nao granule combined with alteplase in treating acute cerebral infarction and its effects on inflammatory factors and coagulation function
文章编号:
1673-7768(2018)04-0574-04
作者:
闫贵国郭淑红石晓娟丁志强章睿梁鹏李伟海
甘肃省酒泉市人民医院神经内科,酒泉市735000
Author(s):
YAN GuiguoGUO ShuhongSHI XiaojuanDING ZhiqiangZHANG RuiLIANG PengLI Weihai
Department of Neurology,Jiuquan City People′s Hospital of Gansu Province,Jiuquan 735000,China
关键词:
急性脑梗死治疗养血清脑颗粒阿替普酶 炎症因子凝血功能
Keywords:
Acute cerebral infarctionCurative effectYangxue Qing GranuleAlteplaseInflammatory factor Coagulation function
分类号:
R 543
DOI:
DOI:10.16121/j.cnki.cn45-1347/r.2018.04.11
文献标志码:
A
摘要:
目的探讨养血清脑颗粒联合阿替普酶治疗急性脑梗死患者的疗效及对患者炎症因子和凝血功能的影响。方法选择2016年1月至2017年9月我院收治的急性脑梗死患者98例为研究对象,根据随机数字表法分为观察组和对照组,每组49例。对照组患者给予阿替普酶溶栓治疗,观察组患者在对照组治疗的基础上加用养血清脑颗粒治疗。比较两组患者的临床疗效;比较两组患者治疗前后的美国国立卫生研究院卒中量表(NIHSS)评分、Barthel指数评分、炎症因子水平和凝血功能的变化情况。结果观察组患者的治疗总有效率(91.84%)显著高于对照组(73.47%),临床疗效优于对照组,差异有统计学意义(P<0.05)。治疗后,两组患者的NIHSS评分均显著降低,观察组患者的NIHSS评分显著低于对照组,差异有统计学意义(P<0.05);两组患者Barthel指数评分均显著提高,观察组患者的Barthel指数评分显著高于对照组,差异有统计学意义(P<0.05);观察组患者的血清IL-1β、CRP、IL-6和TNF-α水平显著降低并且显著低于对照组(P<0.05);两组患者血清PT和APTT水平显著增高、Fib水平显著降低,观察组患者血清PT和APTT水平高于对照组、Fib水平低于对照组,差异有统计学意义(P<0.05)。结论养血清脑颗粒联合阿替普酶溶栓治疗急性脑梗死患者疗效显著,可有效减轻患者的炎症反应并改善凝血功能。
Abstract:
ObjectiveTo investigate the therapeutic efficacy of Yangxue Qing Nao granule combined with alteplase on acute cerebral infarction and its influence on inflammatory factors and coagulation function. MethodsA total of 98 patients with acute cerebral infarction admitted to our hospital from January 2016 to September 2017 were selected as the subjects. According to the random table method, they were divided into observation group and control group,with 49 cases in each group. The control group was treated with thrombolytic therapy with alteplase, and the observation group was combined with Yangxue Qing Nao granule on the basis of the control group. The curative effect of the two groups was compared, and the changes of NIHSS score, Barthel index score, inflammatory factors and coagulation function were compared before and after treatment between the two groups. ResultsThe total effective rate of the observation group (91.84%) was higher than that of the control group (73.47%),with statistical significance (P<0.05).After treatment, the NIHSS score was decreased in both groups,and that in observation group was lower than control group, with statistical significance (P<0.05). The Barthel index score increased in both groups,and that in the observation group was higher than the control group (P<0.05).The serum IL-1β, CRP, IL-6 and TNF-α levels in the observation group were all decreased,which were lower than the control group (P<0.05).PT and APTT levels was increased and Fib was decreased in two groups,while PT and APTT levels in observation group were higher than that of control group,level of Fib was lower than that of control group,with statistical significance (P<0.05). ConclusionYangxue Qing Nao Granules combined with alteplase proves obvious effects in the treatment of acute cerebral infarction by mitigating the inflammatory reaction and improving coagulation function.

相似文献/References:

[1]方志荣,房林燕,段冬云,等.急性脑梗死患者血清超敏C反应蛋白、纤维蛋白原和尿酸与颈动脉粥样硬化的关系[J].内科,2014,(05):523.
 FANG Zhi rong,FANG Lin yan,DUAN Dong yun,et al.Relationship of high sensitivity Creactive protein, fibrinogen, uric acid and carotid artery arteriosclerosis in patients with acute cerebral infarction[J].Internal Medicine of China,2014,(04):523.
[2]华占楼,孙继妹,谢金春,等.早期小剂量地塞米松对急性胰腺炎治疗效果的影响[J].内科,2014,(05):531.
 HUA Zhan lou,SUN Ji mei,XIE Jin chun.Treatment effect of small dosage of dexamethsone in patients with acute pancreatitis in the early time[J].Internal Medicine of China,2014,(04):531.
[3]刘昌灵,何明璋.常规疗法联用盐酸帕罗西汀治疗功能性消化不良的疗效观察[J].内科,2014,(05):534.
 LIU Chang ling,HE Ming zhang.Therapeutic effect of the conventional therapy plus paroxetine on the functional dyspepsia[J].Internal Medicine of China,2014,(04):534.
[4]洪长发.阿奇霉素联合头孢曲松治疗社区获得性肺炎疗效观察[J].内科,2014,(05):546.
[5]骆振波.炎琥宁治疗流行性腮腺炎66例临床疗效观察[J].内科,2014,(05):548.
[6]张喜民,刘文智,豆永强,等.胺碘酮治疗心力衰竭合并室性心律失常63例临床疗效观察[J].内科,2014,(05):552.
[7]莫小琼,蓝惠珍,莫如珍,等.血液透析滤过治疗尿毒症顽固性高血压的疗效观察与护理[J].内科,2014,(05):588.
[8]陶林.曲美他嗪治疗缺血性心肌病心力衰竭30例疗效观察[J].内科,2015,(01):11.[doi:03DOI:10.16121/j.cnki.cn45-1347/r.2015.01.04]
 [J].Internal Medicine of China,2015,(04):11.[doi:03DOI:10.16121/j.cnki.cn45-1347/r.2015.01.04]
[9]胡文标.曲美他嗪治疗缺血性心肌病心力衰竭疗效观察[J].内科,2015,(01):13.[doi:DOI:10.16121/j.cnki.cn45-1347/r.2015.01.05]
 [J].Internal Medicine of China,2015,(04):13.[doi:DOI:10.16121/j.cnki.cn45-1347/r.2015.01.05]
[10]王普.厄贝沙坦治疗轻、中度高血压患者24例的临床疗效观察[J].内科,2015,(01):17.[doi:DOI:10.16121/j.cnki.cn45-1347/r.2015.01.07]
 [J].Internal Medicine of China,2015,(04):17.[doi:DOI:10.16121/j.cnki.cn45-1347/r.2015.01.07]
[11]农媛 樊金莲 肖海.高压氧治疗时机对急性脑梗死疗效影响的临床研究[J].内科,2013,(02):109.
 NONG Yuan,FAN Jin-lian,XIAO Hai.Clinical study of the effect of hyperbaric oxygen therapy started at different time on patients with acute cerebral infarction[J].Internal Medicine of China,2013,(04):109.
[12]陈莉 邹东华 陈娅 曹小丽 秦超 莫雪安.通心络胶囊治疗急性脑梗死的疗效评价[J].内科,2013,(04):345.
 CHEN Li,ZOU Dong-hua,CHEN Ya,et al.Therapeutic effect of tongxinluo capsule on acute cerebral infarction[J].Internal Medicine of China,2013,(04):345.
[13]刘德祥.盐酸法舒地尔治疗急性脑梗死的疗效及对hs-CRP的影响[J].内科,2012,(06):591.
 [J].Internal Medicine of China,2012,(04):591.
[14]古联,谢娟娟,陈炜.依达拉奉联合东菱迪芙治疗急性脑梗死疗效观察▲[J].内科,2011,(06):532.
 GU Lian,XIE Juan-juan,CHEN Wei.Efficacy observation of Edaravone combined with Batroxobin in the treatment of acute cerebral infarction[J].Internal Medicine of China,2011,(04):532.
[15]符达峰,农维昌,王英,等.丁苯酞治疗急性脑梗死患者临床疗效观察[J].内科,2016,(01):83.[doi:DOI:10.16121/j.cnki.cn45-1347/r.2016.01.30]
 [J].Internal Medicine of China,2016,(04):83.[doi:DOI:10.16121/j.cnki.cn45-1347/r.2016.01.30]
[16]梁土金,曾祥富,林武壮.醒脑静注射液联合纤溶酶治疗急性脑梗死患者临床疗效分析[J].内科,2016,(06):905.[doi:DOI:10.16121/j.cnki.cn45-1347/r.2016.06.32]
 [J].Internal Medicine of China,2016,(04):905.[doi:DOI:10.16121/j.cnki.cn45-1347/r.2016.06.32]
[17]曾玮.急性脑梗死后继发癫痫患者的视频脑电图特点分析[J].内科,2016,(06):927.[doi:DOI:10.16121/j.cnki.cn45-1347/r.2016.06.40]
 [J].Internal Medicine of China,2016,(04):927.[doi:DOI:10.16121/j.cnki.cn45-1347/r.2016.06.40]
[18]宋卫红.参芎葡萄糖注射液联合脑蛋白水解物治疗对急性脑梗死患者神经功能及血液流变学的影响[J].内科,2017,12(03):370.[doi:DOI:10.16121/j.cnki.cn451347/r.2017.03.23]
 [J].Internal Medicine of China,2017,12(04):370.[doi:DOI:10.16121/j.cnki.cn451347/r.2017.03.23]
[19]赵旭华.普罗布考联合瑞舒伐他汀治疗急性脑梗死的疗效及对脂质代谢的影响[J].内科,2018,13(02):221.[doi:DOI:10.16121/j.cnki.cn45-1347/r.2018.02.23]
 [J].Internal Medicine of China,2018,13(04):221.[doi:DOI:10.16121/j.cnki.cn45-1347/r.2018.02.23]
[20]张金凤,李光,苏果,等.不明发病时间急性脑梗死患者的CTPI溶栓抉择及疗效评价▲[J].内科,2018,13(04):547.[doi:DOI:10.16121/j.cnki.cn45-1347/r.2018.04.03]
 ZHANG Jinfeng,LI Guang,SU Guo,et al.CTPI examination of patients with acute cerebral infarction with unknown onset time to determine whether thrombolytic therapy and evaluation of its efficacy[J].Internal Medicine of China,2018,13(04):547.[doi:DOI:10.16121/j.cnki.cn45-1347/r.2018.04.03]

更新日期/Last Update: 2018-08-14